Ensifentrine, a Novel PDE3 and PDE4 Inhibitor for the Treatment of COPD: Randomized, Double-Blind, Placebo-controlled, Multicenter, Phase III Trials (The ENHANCE Trials)
Related Posts
Ghantous E, Gao H, Sisniega C, Li A, Aboulhosn J. The utility of 4D intracardiac echocardiography in transcatheter pulmonary valve replacement in adult congenital heart[...]
Samorodnitsky S, Campbell K, Little A, Ling W, Zhao N, Chen YC, Wu MC. Detecting clinically relevant topological structures in multiplexed spatial proteomics using TopKAT.[...]
Rates and Factors Associated With Hepatocellular Carcinoma Diagnosis, Stage, Treatment, and Survival
Ioannou GN, Yakovchenko V, Taddei T, Monto A, Patton H, Merante M, Spoutz P, Chia L, Yudkevich J, Aytaman A, Rabiee A, John B, Blechacz[...]